My Account | Shopping Cart | Contact  
Trilink Biotech Logo

Oligonucleotides | mRNA & Long RNA | Nucleotides | CleanCap® | CleanTag® | CleanAmp® | Custom Chemistry | GMP

OligoBuilder® | Nucleotides List | Stocked mRNA List | DNA Synthesis Reagents List | CleanAmp™ Products List

You are at: All > Oligonucleotides > Custom Oligonucleotide Components > Custom Oligonucleotide Components by Type > Fluorescent Dye Labels

Fluorescein, 6-Carboxyfluorescein


Oligonucleotide Modification Price
0.2 µmole $105
1.0 µmole $131
5.0 µmole $315
10 µmole $420
15 µmole $525
0.2 µmole $158
1.0 µmole $184
5.0 µmole $378
10 µmole $504
15 µmole $630
3' Terminus
0.2 µmole $158
1.0 µmole $184
5.0 µmole $378
10 µmole $504
15 µmole $630

Abs. Max: 496 nm
Em. Max: 516 nm
ε at Abs. Max: 83,000

*This compound requires a primary amine for conjugation onto an oligonucleotide.

Email a Friend
Product Inquiry
Ready to order
your oligonucleotide?

Related Products :

Related Categories :

Sun M, Grigsby IF, Gorelick RJ, Mansky LM, Musier-Forsyth K. Retrovirus-specific differences in matrix and nucleocapsid protein-nucleic acid interactions: implications for genomic RNA packaging. J Virol. 2014 Jan;88(2):1271-80. doi: 10.1128/JVI.02151-13.
Chan CW, Kaplan W, Parish CR, Khachigian LM. Reduced Retinal Microvascular Density, Improved Forepaw Reach, Comparative Microarray and Gene Set Enrichment Analysis with c-jun Targeting DNA Enzyme. PLoS One. 2012;7(7):e39160.
Schettini J, Kidiyoor A, Besmer DM, Tinder TL, Roy LD, Lustgarten J, Gendler SJ, Mukherjee P. Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity. Cancer Immunol Immunother. 2012 Apr 28. doi: 10.1007/s00262-012-
Hernandez FJ, Stockdale KR, Huang L, Horswill AR, Behlke MA, McNamara JO. Degradation of Nuclease-Stabilized RNA Oligonucleotides in Mycoplasma-Contaminated Cell Culture Media. Nucleic Acid Ther. 2012 Jan 9. doi: 10.1089/nat.2011.0316.
Panja S, Woodson SA. Hfq proximity and orientation controls RNA annealing. Nucleic Acids Res. 2012 Jul 2. doi: 10.1093/nar/gks618
Leygue E, Guo J. Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides, Nucleic Acid Research, May 2009, Pubmed. ID: 19483093).



  Twitter Twitter Facebook Facebook Linked In Linked In RSS RSS Google RSS  
© 2018 TriLink BioTechnologies, LLC | All Rights Reserved